Cargando…
Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
Background: Coronary artery disease (CAD) is the leading cause of death worldwide, which has a long asymptomatic period of atherosclerosis. Thus, it is crucial to develop efficient strategies or biomarkers to assess the risk of CAD in asymptomatic individuals. Methods: A total of 356 consecutive CAD...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085268/ https://www.ncbi.nlm.nih.gov/pubmed/33937355 http://dx.doi.org/10.3389/fcvm.2021.619386 |
_version_ | 1783686300020244480 |
---|---|
author | Wu, Dongmei Yang, Qiuju Su, Baohua Hao, Jia Ma, Huirong Yuan, Weilan Gao, Junhui Ding, Feifei Xu, Yue Wang, Huifeng Zhao, Jiangman Li, Bingqiang |
author_facet | Wu, Dongmei Yang, Qiuju Su, Baohua Hao, Jia Ma, Huirong Yuan, Weilan Gao, Junhui Ding, Feifei Xu, Yue Wang, Huifeng Zhao, Jiangman Li, Bingqiang |
author_sort | Wu, Dongmei |
collection | PubMed |
description | Background: Coronary artery disease (CAD) is the leading cause of death worldwide, which has a long asymptomatic period of atherosclerosis. Thus, it is crucial to develop efficient strategies or biomarkers to assess the risk of CAD in asymptomatic individuals. Methods: A total of 356 consecutive CAD patients and 164 non-CAD controls diagnosed using coronary angiography were recruited. Blood lipids, other baseline characteristics, and clinical information were investigated in this study. In addition, low-density lipoprotein cholesterol (LDL-C) subfractions were classified and quantified using the Lipoprint system. Based on these data, we performed comprehensive analyses to investigate the risk factors for CAD development and to predict CAD risk. Results: Triglyceride, LDLC-3, LDLC-4, LDLC-5, LDLC-6, and total small and dense LDL-C were significantly higher in the CAD patients than those in the controls, whereas LDLC-1 and high-density lipoprotein cholesterol (HDL-C) had significantly lower levels in the CAD patients. Logistic regression analysis identified male [odds ratio (OR) = 2.875, P < 0.001], older age (OR = 1.018, P = 0.025), BMI (OR = 1.157, P < 0.001), smoking (OR = 4.554, P < 0.001), drinking (OR = 2.128, P < 0.016), hypertension (OR = 4.453, P < 0.001), and diabetes mellitus (OR = 8.776, P < 0.001) as clinical risk factors for CAD development. Among blood lipids, LDLC-3 (OR = 1.565, P < 0.001), LDLC-4 (OR = 3.566, P < 0.001), and LDLC-5 (OR = 6.866, P < 0.001) were identified as risk factors. To predict CAD risk, six machine learning models were constructed. The XGboost model showed the highest AUC score (0.945121), which could distinguish CAD patients from the controls with a high accuracy. LDLC-4 played the most important role in model construction. Conclusions: The established models showed good performance for CAD risk prediction, which can help screen high-risk CAD patients in asymptomatic population, so that further examination and prevention treatment might be taken before any sudden or serious event. |
format | Online Article Text |
id | pubmed-8085268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80852682021-05-01 Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development Wu, Dongmei Yang, Qiuju Su, Baohua Hao, Jia Ma, Huirong Yuan, Weilan Gao, Junhui Ding, Feifei Xu, Yue Wang, Huifeng Zhao, Jiangman Li, Bingqiang Front Cardiovasc Med Cardiovascular Medicine Background: Coronary artery disease (CAD) is the leading cause of death worldwide, which has a long asymptomatic period of atherosclerosis. Thus, it is crucial to develop efficient strategies or biomarkers to assess the risk of CAD in asymptomatic individuals. Methods: A total of 356 consecutive CAD patients and 164 non-CAD controls diagnosed using coronary angiography were recruited. Blood lipids, other baseline characteristics, and clinical information were investigated in this study. In addition, low-density lipoprotein cholesterol (LDL-C) subfractions were classified and quantified using the Lipoprint system. Based on these data, we performed comprehensive analyses to investigate the risk factors for CAD development and to predict CAD risk. Results: Triglyceride, LDLC-3, LDLC-4, LDLC-5, LDLC-6, and total small and dense LDL-C were significantly higher in the CAD patients than those in the controls, whereas LDLC-1 and high-density lipoprotein cholesterol (HDL-C) had significantly lower levels in the CAD patients. Logistic regression analysis identified male [odds ratio (OR) = 2.875, P < 0.001], older age (OR = 1.018, P = 0.025), BMI (OR = 1.157, P < 0.001), smoking (OR = 4.554, P < 0.001), drinking (OR = 2.128, P < 0.016), hypertension (OR = 4.453, P < 0.001), and diabetes mellitus (OR = 8.776, P < 0.001) as clinical risk factors for CAD development. Among blood lipids, LDLC-3 (OR = 1.565, P < 0.001), LDLC-4 (OR = 3.566, P < 0.001), and LDLC-5 (OR = 6.866, P < 0.001) were identified as risk factors. To predict CAD risk, six machine learning models were constructed. The XGboost model showed the highest AUC score (0.945121), which could distinguish CAD patients from the controls with a high accuracy. LDLC-4 played the most important role in model construction. Conclusions: The established models showed good performance for CAD risk prediction, which can help screen high-risk CAD patients in asymptomatic population, so that further examination and prevention treatment might be taken before any sudden or serious event. Frontiers Media S.A. 2021-04-16 /pmc/articles/PMC8085268/ /pubmed/33937355 http://dx.doi.org/10.3389/fcvm.2021.619386 Text en Copyright © 2021 Wu, Yang, Su, Hao, Ma, Yuan, Gao, Ding, Xu, Wang, Zhao and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Wu, Dongmei Yang, Qiuju Su, Baohua Hao, Jia Ma, Huirong Yuan, Weilan Gao, Junhui Ding, Feifei Xu, Yue Wang, Huifeng Zhao, Jiangman Li, Bingqiang Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development |
title | Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development |
title_full | Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development |
title_fullStr | Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development |
title_full_unstemmed | Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development |
title_short | Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development |
title_sort | low-density lipoprotein cholesterol 4: the notable risk factor of coronary artery disease development |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085268/ https://www.ncbi.nlm.nih.gov/pubmed/33937355 http://dx.doi.org/10.3389/fcvm.2021.619386 |
work_keys_str_mv | AT wudongmei lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT yangqiuju lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT subaohua lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT haojia lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT mahuirong lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT yuanweilan lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT gaojunhui lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT dingfeifei lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT xuyue lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT wanghuifeng lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT zhaojiangman lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment AT libingqiang lowdensitylipoproteincholesterol4thenotableriskfactorofcoronaryarterydiseasedevelopment |